Navigation Links
BioFortis Wins Best Product Award in Discovery Informatics at the 2009 Molecular Medicine Tri-Conference
Date:3/5/2009

Biomedical Informatics Market Leader BioFortis wins another award for its Labmatrix(TM) platform being used by leading pharmaceutical and institutional clients worldwide for translational research, biomarker discovery, biobanking, and clinical research

COLUMBIA, Md., March 5 /PRNewswire/ -- BioFortis, Inc., the leading provider of biomedical informatics solutions used by pharmaceutical and institutional clients, today announced it has won the 2009 Molecular Medicine Tri-Conference "Best Product Award" for its leading Labmatrix(TM) platform. The award is given to the best peer-reviewed solution at the annual conference.

The Best Product Award honored companies that launched the best products at the 2009 Molecular Medicine Tri-Conference. Approximately 2600 attendees of the conference were invited to vote on the contestants' products and the winners were announced at a special ceremony.

Labmatrix(TM) was designed as a solution to enable a comprehensive "bench-to-bedside" approach to the study of human diseases, while permitting collaboration in a secure environment that facilitates regulatory compliance. Labmatrix(TM) provides a clear competitive advantage for organizations that must keep pace in an era of new, high-throughput technologies utilized in discovery programs focused on next-generation therapeutics. BioFortis is the leader in information management for translational research, biomarker discovery, biobanking and clinical research, supporting multiple pharmaceutical clients and research institutions in their mission of speeding drug discovery and driving personalized medicine into practice.

"We are thrilled to win this award," said Jian Wang, BioFortis CEO, "especially considering it is an award voted on by researchers directly. This validates our mission to create data management and exploration tools that are so easy scientists can use effectively from day one. This award reaffirms our leadership position in providing informatics solutions for translational and biomarker researchers."

About BioFortis

BioFortis is a leading provider of biomedical informatics solutions. Our lead product, Labmatrix(TM), addresses research needs of the post-genomic era within several key application areas including translational research, biobanking, biomarker discovery and clinical research. Labmatrix(TM) is a web-based software application for the management and exploration of clinical, specimen and molecular assay data. With the ability to integrate these data sets in a tightly linked, highly annotated manner, Labmatrix(TM) is being used by customers in the biopharmaceutical industry, academia and government research institutions.

BioFortis and Labmatrix(TM) are registered trademarks of BioFortis, Inc.

www.biofortis.com


'/>"/>
SOURCE BioFortis, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. House Committee Vote Sets Congress on Course for Historic Regulation of Tobacco Products
2. On March 4, 2009, The United States Supreme Court Rejected the Rationale Behind Michigans Drug Product Liability Law
3. MedX Health Receives CE Mark for Laser & Light Products
4. a la mode Bra Fitting Specialty Boutique Now Has Trained Fitters and Products for Women Who Are Post Op Mastectomy or Lumpectomy
5. Johnson Institute Transfers Key Programs and Products to Hazelden Foundation
6. Congress Can Deliver Historic Victory for Children and Americas Health By Granting FDA Authority Over Tobacco Products
7. Best New Product Awards Winners Named at Molecular Medicine Tri-Conference
8. Halo Pharmaceutical Launches a Branded Product Marketing Company in Canada
9. Prudential Long-Term Care Product Simplifies Decisions
10. Natural Products Association Comments on New GAO Report on Regulation of Dietary Supplements
11. Thermogenesis Technology Products Surpass Processing of More Than One Million Units of Cord Blood Stem Cells at 10-Year Milestone
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2016)... ... ... Lori G. Cohen and Sara K. Thompson , shareholders in global law ... 21st Drug & Medical Device Litigation Conference , taking place in New York Dec. ... chairs the firm’s Pharmaceutical, Medical Device & Health Care Litigation Practice and the Trial ...
(Date:12/2/2016)... ... , ... Advanced Inc., a leading provider of travel therapy and travel nursing ... as Advanced Inc.’s Chief Financial Officer, effective December 1, 2016. Jason previously served as ... operational leadership experience to Advanced Inc. He began his career in finance at Ernst ...
(Date:12/2/2016)... ... ... With the number of pain management programs available for people suffering with constant ... works for them. When an inventor from Suisun City, Calif., was unsuccessful in finding ... it with others. , He developed a prototype for PRO GO MASSAGE to relieve ...
(Date:12/2/2016)... ... December 02, 2016 , ... CloudLIMS.com, a ... SaaS LIMS, CloudLIMS Lite. CloudLIMS Lite helps biobanks, clinical, research and testing laboratories ... and disposal. The new version is a faster and a more efficient product, ...
(Date:12/2/2016)... ... 02, 2016 , ... Yisrayl Hawkins, at The House of Yahweh in Abilene, ... into Bible Prophecy. Yisrayl says this generation, known as the Last Generation, started in ... the details line up exactly with Bible Prophecy – a protected way for those ...
Breaking Medicine News(10 mins):
(Date:12/2/2016)... , December 2, 2016 On ... Committee honored excellence in research, development and innovation in ... gala dinner was held in the presence of Sergey ... Russian Federation , Natalia Sanina, First ... Mikhail Murashko , Head of Roszdravnadzor, National Service of ...
(Date:12/2/2016)... CVS Health Corporation (NYSE: CVS ... City on Thursday, December 15, 2016, beginning at 8:00 a.m. (ET). Senior ... an in-depth review of the company,s strategies to drive ... also discuss 2017 earnings guidance during the event. ... will be broadcast simultaneously on the Investor Relations portion ...
(Date:12/2/2016)... -- On Thursday, the NASDAQ Composite and the ... Dow Jones Industrial Average managed to stay in green. Losses ... prompted Stock-callers this morning to look at the performances of ... ), Smith & Nephew PLC (NYSE: SNN ), ... Therapeutics Inc. (NASDAQ: KOOL ). You can access ...
Breaking Medicine Technology: